Leonard L Sokol1,2, Danny Bega1,3, Chen Yeh4, Benzi M Kluger5,6, Hillary D Lum7,8. 1. The Ken and Ruth Davee Department of Neurology, 12244Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 2. McGaw Bioethics Scholars Program, Center for Bioethics and Humanities, 12244Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. Division of Movement Disorders, The Ken and Ruth Davee Department of Neurology, 12244Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Department of Preventive Medicine, 12244Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 5. Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. 6. Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. 7. Eastern Colorado VA Geriatric Research Education and Clinical Center, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. 8. Division of Geriatric Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Abstract
BACKGROUND: People with Huntington's disease (HD) often become institutionalized and more frequently die away from the home setting. The reasons behind differences in end-of-life care are poorly understood. Less than 5% of people with HD report utilization of palliative care (PC) or hospice services, regardless of the lack of curative therapies for this neurodegenerative disease. It is unknown what factors are associated with in-patient specialty PC consultation in this population and how PC might be related to discharge disposition. OBJECTIVES: To determine what HD-specific (e.g., psychosis) and serious illness-specific factors (e.g., resuscitation preferences) are associated with PC encounters in people with HD and explore how PC encounters are associated with discharge disposition. DESIGN: We analyzed factors associated with PC consultation for people with HD using discharge data from the National Inpatient Sample and the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. An anonymized, cross-sectional, and stratified sample of 20% of United States hospitalizations from 2007 through 2014 were included using ICD-9 codes. RESULTS: 8521 patients with HD were admitted to the hospital. Of those, 321 (3.8%) received specialty PC. Payer type, (specifically private insurer or other insurer as compared to Medicare), income, (specifically the top quartile as compared to the bottom quartile), mortality risk, D.N.R., aspiration pneumonia, and depression were significantly associated with PC in a multivariate model. Among those who received PC, the odds ratio (OR) of discharge to a facility was 0.43 (95% CI, 0.32-0.58), whereas the OR of discharge to home with services was 2.25 (95% CI 1.57-3.23), even after adjusting for possible confounders. CONCLUSIONS: Among patients with HD, economic factors, depression, and serious illness-specific factors were associated with PC, and PC was associated with discharge disposition. These findings have implications for the adaptation of inpatient PC models to meet the needs of persons with HD.
BACKGROUND: People with Huntington's disease (HD) often become institutionalized and more frequently die away from the home setting. The reasons behind differences in end-of-life care are poorly understood. Less than 5% of people with HD report utilization of palliative care (PC) or hospice services, regardless of the lack of curative therapies for this neurodegenerative disease. It is unknown what factors are associated with in-patient specialty PC consultation in this population and how PC might be related to discharge disposition. OBJECTIVES: To determine what HD-specific (e.g., psychosis) and serious illness-specific factors (e.g., resuscitation preferences) are associated with PC encounters in people with HD and explore how PC encounters are associated with discharge disposition. DESIGN: We analyzed factors associated with PC consultation for people with HD using discharge data from the National Inpatient Sample and the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. An anonymized, cross-sectional, and stratified sample of 20% of United States hospitalizations from 2007 through 2014 were included using ICD-9 codes. RESULTS: 8521 patients with HD were admitted to the hospital. Of those, 321 (3.8%) received specialty PC. Payer type, (specifically private insurer or other insurer as compared to Medicare), income, (specifically the top quartile as compared to the bottom quartile), mortality risk, D.N.R., aspiration pneumonia, and depression were significantly associated with PC in a multivariate model. Among those who received PC, the odds ratio (OR) of discharge to a facility was 0.43 (95% CI, 0.32-0.58), whereas the OR of discharge to home with services was 2.25 (95% CI 1.57-3.23), even after adjusting for possible confounders. CONCLUSIONS: Among patients with HD, economic factors, depression, and serious illness-specific factors were associated with PC, and PC was associated with discharge disposition. These findings have implications for the adaptation of inpatient PC models to meet the needs of persons with HD.
Entities:
Keywords:
Huntington disease; end-of-life; neuropalliative care; palliative care
Authors: Noelle E Carlozzi; Nicholas R Boileau; Jane S Paulsen; Joel S Perlmutter; Jin-Shei Lai; Elizabeth A Hahn; Michael K McCormack; Martha A Nance; David Cella; Stacey K Barton; Nancy R Downing Journal: J Neurol Date: 2019-06-12 Impact factor: 4.849
Authors: Joshua R Lakin; Margaret G Robinson; Rachelle E Bernacki; Brian W Powers; Susan D Block; Rebecca Cunningham; Ziad Obermeyer Journal: JAMA Intern Med Date: 2016-12-01 Impact factor: 21.873
Authors: V L Wheelock; T Tempkin; K Marder; M Nance; R H Myers; H Zhao; E Kayson; C Orme; I Shoulson Journal: Neurology Date: 2003-03-25 Impact factor: 9.910
Authors: Leonard L Sokol; Hillary D Lum; Claire J Creutzfeldt; David Cella; Jodi Forlizzi; Moran Cerf; Joshua M Hauser; Benzi M Kluger Journal: J Palliat Med Date: 2020-09 Impact factor: 2.947